The Oncology Shot with Timothee Olivier

Substacknewsletter · by Timothée Olivier · English

My Personal Substack

Audience
7K subscribers
Shown publicly on Substack
Observed frequency
Weekly
From 9 posts indexed in the last 90 days
Last post
Nov 11, 2026
6 days ago
Likely audience
Oncologists
Inferred from post content

The Oncology Shot with Timothee Olivier is a Substack newsletter by Timothée Olivier covering Oncology clinical trials, daraxonrasib pancreatic cancer treatment and RASolute 302 clinical trial results. NewsletterFIT indexed 9 posts from it in the last 90 days, most recently on Nov 11, 2026. Shown publicly on Substack: 7K subscribers.

Topics

  • Oncology clinical trials
  • daraxonrasib pancreatic cancer treatment
  • RASolute 302 clinical trial results
  • RAS(ON) inhibitors
  • radiotherapy clinical trials in pancreatic cancer

Recent posts

  • Do we…
  • Currency of…
  • My MD-Anderson…
  • Not One,…
  • What to…
  • The forgotten…

Sponsors detected

No sponsored posts detected in the last 180 days of indexed posts.

Detected automatically from posts marked as sponsored. Detection can miss or misread placements.

See the full picture on The Oncology Shot with Timothee Olivier

Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.

Start 7-day Pro trial

The Oncology Shot with Timothee Olivier alternatives: similar newsletters

Ranked by how many topics they share with The Oncology Shot with Timothee Olivier.

  • SubstackMonthly or less · last post Sep 3, 2026

    Likely audience: Biotech investors

    1 shared topic

All The Oncology Shot with Timothee Olivier alternatives →

Compiled from public pages · refreshed Nov 16, 2026 · How NewsletterFIT collects and labels data